Duane Retraction Syndrome

👪

Inheritance

1

Autosomal dominant inheritance HP:0000006

Autosomal dominant inheritance

Show evidence (2 references)

PMID:20301369 SUPPORT Human Clinical

"Duane syndrome resulting from a CHN1, MAFB, or SALL4 pathogenic variant is inherited in an autosomal dominant manner."

GeneReviews establishes autosomal dominant inheritance for the identified Mendelian (CHN1/MAFB/SALL4) forms of Duane syndrome.

PMID:8310396 SUPPORT Human Clinical

"Most cases are sporadic, but familial cases have been estimated at 10% by most authors."

Documents that most DRS is sporadic with roughly 10% familial, the context in which the autosomal dominant Mendelian forms occur.

◆

Subtypes

3

Type 1 (Huber type I, limited abduction)

The most common clinical subtype, characterized by markedly limited or absent abduction with relatively preserved adduction, typically with esotropia in primary gaze. Corresponds to absent/hypoplastic abducens nerve innervation of the lateral rectus.

Type 2 (Huber type II, limited adduction)

Limited adduction with relatively preserved abduction, often with exotropia in primary gaze, attributed to anomalous oculomotor co-innervation of the lateral rectus that opposes adduction.

Type 3 (Huber type III, limited abduction and adduction)

Limitation of both abduction and adduction, with pronounced globe retraction on attempted adduction, reflecting the most extensive aberrant co-innervation of the horizontal recti.

⚙

Pathophysiology

4

CHN1 Hyperactivation and MAFB Loss Disrupt Abducens Motor Neuron Development

In the Mendelian forms of DRS, distinct molecular lesions converge on the development of abducens (sixth nerve) motor neurons. Gain-of-function missense variants in CHN1 hyperactivate alpha2-chimaerin, a Rac GTPase-activating (RacGAP) signaling protein that controls cytoskeletal dynamics during ocular motor axon pathfinding. Loss of function of MAFB, a transcription factor required for abducens motor neuron identity, removes a key determinant of sixth-nerve specification. Both lesions perturb the genetic program that builds the abducens nerve.

abducens motor neuron CL:0000100

regulation of Rac protein signal transduction GO:0035020 ↕ DYSREGULATED motor neuron axon guidance GO:0008045 ↕ DYSREGULATED Semaphorin-plexin signaling upstream of alpha2-chimaerin GO:0071526 ↕ DYSREGULATED ephrin/EphA4 receptor signaling upstream of alpha2-chimaerin GO:0048013 ↕ DYSREGULATED

Downstream

Abducens Nerve Hypoplasia and Failure to Innervate the Lateral Rectus Disrupted abducens motor neuron development leads to hypoplasia of the sixth nerve and failure to innervate the lateral rectus muscle.

Show evidence (5 references)

PMID:18653847 SUPPORT Human Clinical

"Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes alpha2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein"

Identifies heterozygous CHN1 missense mutations encoding the alpha2-chimaerin RacGAP as the cause of the DURS2 form of DRS.

PMID:18653847 SUPPORT In Vitro

"We found that these are gain-of-function mutations that increase alpha2-chimaerin RacGAP activity in vitro."

Establishes the CHN1 variants as gain-of-function, increasing RacGAP activity and thereby dysregulating Rac signaling.

PMID:28459979 SUPPORT Human Clinical

"It can be caused by decreased function of several transcription factors critical for abducens motor neuron identity, including MAFB, or by heterozygous missense mutations in CHN1"

Names reduced MAFB transcription-factor function and CHN1 missense variants as causes acting on abducens motor neuron identity and development.

+ 2 more references

Abducens Nerve Hypoplasia and Failure to Innervate the Lateral Rectus

The primary anatomical lesion of DRS is hypoplasia or absence of the abducens nerve, which fails to fully innervate the lateral rectus muscle. Postmortem and mouse studies establish this as the founding event from which the downstream miswiring follows. This denervation underlies the limitation of abduction.

abducens motor neuron CL:0000100

abducens nerve development GO:0021560 ↓ DECREASED

Downstream

Aberrant Oculomotor Nerve Reinnervation of the Lateral Rectus The denervated lateral rectus is secondarily reinnervated by an aberrant branch of the oculomotor nerve.

Show evidence (4 references)

PMID:20301369 SUPPORT Human Clinical

"The lateral movement anomaly results from failure of the abducens nucleus and nerve (cranial nerve VI) to fully innervate the lateral rectus muscle"

GeneReviews states the abduction deficit results from failure of the abducens nucleus and nerve to innervate the lateral rectus.

PMID:27181683 SUPPORT Human Clinical

"Postmortem studies of DRS have reported abducens nerve hypoplasia and aberrant innervation of the lateral rectus muscle by the oculomotor nerve."

Documents the human postmortem pathology of abducens nerve hypoplasia underlying DRS.

PMID:27181683 SUPPORT Model Organism

"we present evidence that the primary cause of DRS is failure of the abducens nerve to fully innervate the lateral rectus muscle in early development."

Mouse modeling identifies failed abducens innervation of the lateral rectus as the primary developmental cause of DRS.

+ 1 more reference

Aberrant Oculomotor Nerve Reinnervation of the Lateral Rectus

With the abducens nerve absent or hypoplastic, the lateral rectus is aberrantly reinnervated by misrouted branches of the oculomotor (third) nerve that form near the target extraocular muscles. The lateral rectus is thereby wired to fire with the medial rectus during attempted adduction rather than during abduction.

aberrant oculomotor motor neuron CL:0000100 lateral rectus muscle cell CL:0000188

ocular motor axon guidance GO:0008045 ⚠ ABNORMAL

Downstream

Co-contraction of the Horizontal Recti and Globe Retraction Shared innervation makes the lateral and medial recti co-contract on adduction, retracting the globe and limiting horizontal movement.

Show evidence (4 references)

PMID:20301369 SUPPORT Human Clinical

"globe retraction occurs as a result of abnormal innervation of the lateral rectus muscle by the oculomotor nerve (cranial nerve III)"

GeneReviews attributes the globe retraction to abnormal oculomotor-nerve innervation of the lateral rectus.

PMID:27181683 SUPPORT Model Organism

"we demonstrate that selectively disrupting abducens nerve development is sufficient to cause secondary innervation of the lateral rectus muscle by aberrant oculomotor nerve branches, which form at developmental decision regions close to target extraocular muscles."

Mouse experiments show that abducens disruption is sufficient to trigger secondary aberrant oculomotor reinnervation of the lateral rectus.

PMID:18653847 SUPPORT Model Organism

"Expression of mutant alpha2-chimaerin constructs in chick embryos resulted in failure of oculomotor axons to innervate their target extraocular muscles."

Chick-embryo expression of mutant alpha2-chimaerin disrupts oculomotor axon targeting of extraocular muscles, modeling the miswiring mechanism.

+ 1 more reference

Co-contraction of the Horizontal Recti and Globe Retraction

Because the lateral rectus is innervated by the oculomotor nerve along with the medial rectus, attempted adduction drives simultaneous contraction (co-contraction) of both horizontal recti. The opposing forces pull the globe posteriorly into the orbit, producing the characteristic globe retraction and narrowing of the palpebral fissure, while abduction remains deficient. Upshoot or downshoot of the eye on adduction can result from the co-contracting lateral rectus slipping over or under the globe.

horizontal rectus muscle cell CL:0000188

Show evidence (2 references)

PMID:8310396 SUPPORT Human Clinical

"the characteristic findings are best explained by a paradoxical innervation of the lateral rectus muscle, which subsequently causes a cocontraction of the horizontal rectus muscles."

Establishes co-contraction of the horizontal recti from paradoxical lateral rectus innervation as the mechanism of the clinical findings.

PMID:20301369 SUPPORT Human Clinical

"the globe retracts into the orbit with attempted adduction, accompanied by narrowing of the palpebral fissure"

Describes the globe retraction and palpebral fissure narrowing on adduction that result from the co-contraction.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

10

Ear 1

Sensorineural Hearing Impairment Sensorineural hearing impairment HP:0000407

Show evidence (1 reference)

PMID:27181683 SUPPORT Human Clinical

"Here, we report on three heterozygous loss-of-function MAFB mutations causing DRS and a dominant-negative MAFB mutation causing DRS and deafness."

Documents the MAFB dominant-negative variant causing DRS together with deafness (inner-ear defect).

Eye 2

Upshoot or Downshoot on Adduction Abnormality of eye movement HP:0000496

Show evidence (1 reference)

PMID:8310396 SUPPORT Human Clinical

"retraction of the globe with narrowing of the lid fissure in attempted adduction, frequent abduction deficiency with variable limitation to adduction, and upshoot and/or downshoot of the affected eye on adduction."

The classic description of DRS lists upshoot and/or downshoot on adduction as part of the defining triad.

Strabismus Strabismus HP:0000486

Show evidence (1 reference)

PMID:31322716 SUPPORT Human Clinical

"Strabismus in primary position was present in 57 patients (46%), of whom 39% had esotropia and 61% had exotropia."

Cohort data quantify primary-position strabismus and the esotropia/exotropia split in DRS.

Other 7

Duane Anomaly Duane anomaly HP:0009921

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"Duane syndrome is a strabismus condition clinically characterized by congenital non-progressive limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure."

GeneReviews defines the core Duane anomaly phenotype.

Impaired Ocular Abduction Impaired ocular abduction HP:0000634

Show evidence (1 reference)

PMID:8310396 SUPPORT Human Clinical

"retraction of the globe with narrowing of the lid fissure in attempted adduction, frequent abduction deficiency with variable limitation to adduction, and upshoot and/or downshoot of the affected eye on adduction."

Documents the frequent abduction deficiency characteristic of DRS.

Impaired Ocular Adduction Impaired ocular adduction HP:0000542

Show evidence (1 reference)

PMID:8310396 SUPPORT Human Clinical

"frequent abduction deficiency with variable limitation to adduction"

Documents the variable adduction limitation seen in DRS, prominent in the type 2 pattern.

Palpebral Fissure Narrowing on Adduction Palpebral fissure narrowing on adduction HP:0000661

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"the globe retracts into the orbit with attempted adduction, accompanied by narrowing of the palpebral fissure"

Describes the palpebral fissure narrowing accompanying globe retraction on adduction.

Amblyopia Amblyopia HP:0000646

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"Individuals with Duane syndrome who lack binocular vision are at risk for amblyopia."

GeneReviews identifies amblyopia risk in DRS individuals without binocular vision.

Compensatory Abnormal Head Posture Compensatory head posture HP:0031705

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"Many individuals with Duane syndrome have strabismus in primary gaze but can use a compensatory head turn to align the eyes"

GeneReviews documents the compensatory head turn used to maintain alignment.

Refractive Error Abnormality of refraction HP:0000539

Show evidence (1 reference)

PMID:31322716 SUPPORT Human Clinical

"Ametropia was found in 94 patients (79%), amblyopia was present in 15 patients (13%), and 41 patients (34%) underwent surgery."

Cohort data document the high frequency of ametropia (and amblyopia) in DRS.

🧬

Genetic Associations

3

CHN1 (Causative)

Gene: CHN1 (alpha2-chimaerin, RacGAP) hgnc:1943

Show evidence (1 reference)

PMID:18653847 SUPPORT Human Clinical

"Studying families with a variant form of the disorder (DURS2-DRS), we have identified causative heterozygous missense mutations in CHN1, a gene on chromosome 2q31 that encodes alpha2-chimaerin, a Rac guanosine triphosphatase-activating protein (RacGAP) signaling protein"

Establishes heterozygous CHN1 gain-of-function missense variants as the cause of the DURS2 form of DRS.

MAFB (Causative)

Gene: MAFB (abducens motor neuron identity transcription factor) hgnc:6408

Show evidence (1 reference)

PMID:27181683 SUPPORT Human Clinical

"Here, we report on three heterozygous loss-of-function MAFB mutations causing DRS and a dominant-negative MAFB mutation causing DRS and deafness."

Establishes heterozygous loss-of-function MAFB variants (and a dominant-negative allele with deafness) as a cause of DRS.

SALL4 (Causative)

Gene: SALL4 (Duane-radial ray / Okihiro spectrum) hgnc:15924

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"Molecular genetic testing for a pathogenic variant in CHN1, MAFB, or SALL4 is most appropriate for those with a positive family history of isolated Duane syndrome"

GeneReviews lists SALL4 among the genes tested in Duane syndrome; SALL4 variants underlie the syndromic Duane-radial ray (Okihiro) spectrum.

💊

Medical Actions

4

Extraocular Muscle (Strabismus) Surgery

Action: strabismus surgery MAXO:0025006

Surgical recession/transposition of the extraocular muscles to improve alignment in primary gaze, reduce a compensatory head posture, and address upshoot or downshoot. Surgery does not restore normal abduction but rebalances the eyes.

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"extraocular muscle surgery to address alignment in primary gaze, compensatory head posture, and upshoot or downshoot."

GeneReviews specifies extraocular muscle surgery for alignment, head posture, and upshoot/downshoot in DRS.

Amblyopia Therapy

Action: occlusion or penalization therapy for amblyopia Ontology label: supportive care MAXO:0000950

Occlusion or penalization of the better-seeing eye to treat or prevent amblyopia in the affected eye, particularly in individuals lacking binocular vision.

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"occlusion or penalization of the better-seeing eye for treatment of amblyopia"

GeneReviews specifies occlusion/penalization of the better-seeing eye for amblyopia management.

Botulinum Toxin Chemodenervation

Action: botulinum toxin chemodenervation Ontology label: Pharmacotherapy NCIT:C15986

Agent: botulinum toxin type A CHEBI:3160

Injection of botulinum toxin type A into the horizontal recti (typically the ipsilateral medial rectus in esotropic DRS) to weaken co-contraction and reduce the primary-position deviation and abnormal head posture. Effect is temporary and often requires repeat injection or subsequent surgery, but it can improve alignment and quality of life and serve a diagnostic role before surgery.

Show evidence (1 reference)

PMID:35446195 SUPPORT Human Clinical

"There was a significant reduction in ocular deviation in esotropic and exotropic Duane retraction syndrome at 10 days (P = .001) and 3 months (P = .04) after botulinum toxin injection."

Interventional case series showing botulinum toxin A significantly reduces ocular deviation in esotropic and exotropic DRS.

Optical Correction (Spectacles and Prisms)

Action: refractive correction and prism therapy Ontology label: supportive care MAXO:0000950

Spectacles or contact lenses to correct refractive error, and prism glasses (usually in older individuals with mild involvement) to improve a compensatory head position.

Show evidence (1 reference)

PMID:20301369 SUPPORT Human Clinical

"Spectacles or contact lenses for refractive error; occlusion or penalization of the better-seeing eye for treatment of amblyopia; prism glasses (usually in older individuals with mild involvement) to improve the compensatory head position"

GeneReviews specifies refractive correction and prism glasses for DRS management.

{ }

Source YAML

click to show

name: Duane Retraction Syndrome
creation_date: "2026-06-25T00:00:00Z"
category: Mendelian
disease_term:
  preferred_term: Duane retraction syndrome
  term:
    id: MONDO:0007473
    label: Duane retraction syndrome
description: >-
  Duane retraction syndrome (DRS) is a congenital, non-progressive ocular
  cranial dysinnervation disorder (CCDD) and the most common form of congenital
  paralytic strabismus. The primary lesion is maldevelopment of the abducens
  (sixth cranial nerve) nucleus and nerve, which fails to fully innervate the
  lateral rectus muscle. During embryogenesis the denervated lateral rectus is
  secondarily and aberrantly reinnervated by a misrouted branch of the
  oculomotor (third cranial) nerve. Because the lateral rectus then fires
  together with the medial rectus, attempted adduction produces co-contraction
  of the horizontal recti, pulling the globe back into the orbit (globe
  retraction) with narrowing of the palpebral fissure, while abduction is
  limited. DRS is clinically classified by the Huber electromyographic scheme
  into type 1 (limited abduction), type 2 (limited adduction), and type 3
  (limited abduction and adduction). The great majority of cases are isolated
  and sporadic; roughly 10% are familial, and identified Mendelian forms are
  autosomal dominant — gain-of-function CHN1 variants (DURS2), loss-of-function
  MAFB variants (which can co-segregate with deafness), and SALL4 variants in the
  syndromic Duane-radial ray (Okihiro) spectrum. DRS sits within the wider CCDD
  family alongside congenital fibrosis of the extraocular muscles and Mobius
  syndrome, all of which arise from maldevelopment or miswiring of ocular motor
  cranial nerves rather than from a primary muscle defect.
parents:
- congenital nervous system disorder
- hereditary neurological disease
- disorder of development or morphogenesis
inheritance:
- name: Autosomal dominant inheritance
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Duane syndrome resulting from a CHN1, MAFB, or SALL4 pathogenic variant is
      inherited in an autosomal dominant manner.
    explanation: >-
      GeneReviews establishes autosomal dominant inheritance for the identified
      Mendelian (CHN1/MAFB/SALL4) forms of Duane syndrome.
  - reference: PMID:8310396
    reference_title: "Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Most cases are sporadic, but familial cases have been estimated at 10% by
      most authors.
    explanation: >-
      Documents that most DRS is sporadic with roughly 10% familial, the context
      in which the autosomal dominant Mendelian forms occur.
references:
- reference: PMID:20301369
  title: "Duane Syndrome."
  tags:
  - GeneReviews
- reference: PMID:18653847
  title: "Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome."
- reference: PMID:27181683
  title: "Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects."
- reference: PMID:28459979
  title: "Ocular congenital cranial dysinnervation disorders (CCDDs): insights into axon growth and guidance."
- reference: PMID:22912401
  title: "Axon guidance in the developing ocular motor system and Duane retraction syndrome depends on Semaphorin signaling via alpha2-chimaerin."
- reference: PMID:28346224
  title: "Mutant alpha2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome."
- reference: PMID:8310396
  title: "Duane's retraction syndrome."
- reference: PMID:31322716
  title: "Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review."
- reference: PMID:40212284
  title: "Etiology and clinical features of Han Chinese patients with Duane retraction syndrome."
- reference: PMID:35446195
  title: "Duane Retraction Syndrome: The Role of Botulinum Toxin A Injection in Adults and Its Impact on Quality of Life in an Indian Population."
has_subtypes:
- name: Type 1
  display_name: Type 1 (Huber type I, limited abduction)
  description: >-
    The most common clinical subtype, characterized by markedly limited or
    absent abduction with relatively preserved adduction, typically with
    esotropia in primary gaze. Corresponds to absent/hypoplastic abducens nerve
    innervation of the lateral rectus.
- name: Type 2
  display_name: Type 2 (Huber type II, limited adduction)
  description: >-
    Limited adduction with relatively preserved abduction, often with exotropia
    in primary gaze, attributed to anomalous oculomotor co-innervation of the
    lateral rectus that opposes adduction.
- name: Type 3
  display_name: Type 3 (Huber type III, limited abduction and adduction)
  description: >-
    Limitation of both abduction and adduction, with pronounced globe retraction
    on attempted adduction, reflecting the most extensive aberrant
    co-innervation of the horizontal recti.
pathophysiology:
- name: CHN1 Hyperactivation and MAFB Loss Disrupt Abducens Motor Neuron Development
  description: >-
    In the Mendelian forms of DRS, distinct molecular lesions converge on the
    development of abducens (sixth nerve) motor neurons. Gain-of-function
    missense variants in CHN1 hyperactivate alpha2-chimaerin, a Rac
    GTPase-activating (RacGAP) signaling protein that controls cytoskeletal
    dynamics during ocular motor axon pathfinding. Loss of function of MAFB, a
    transcription factor required for abducens motor neuron identity, removes a
    key determinant of sixth-nerve specification. Both lesions perturb the
    genetic program that builds the abducens nerve.
  cell_types:
  - preferred_term: abducens motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  biological_processes:
  - preferred_term: regulation of Rac protein signal transduction
    term:
      id: GO:0035020
      label: regulation of Rac protein signal transduction
    modifier: DYSREGULATED
  - preferred_term: motor neuron axon guidance
    term:
      id: GO:0008045
      label: motor neuron axon guidance
    modifier: DYSREGULATED
  - preferred_term: Semaphorin-plexin signaling upstream of alpha2-chimaerin
    term:
      id: GO:0071526
      label: semaphorin-plexin signaling pathway
    modifier: DYSREGULATED
  - preferred_term: ephrin/EphA4 receptor signaling upstream of alpha2-chimaerin
    term:
      id: GO:0048013
      label: ephrin receptor signaling pathway
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:18653847
    reference_title: "Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Studying families with a variant form of the disorder (DURS2-DRS), we have
      identified causative heterozygous missense mutations in CHN1, a gene on
      chromosome 2q31 that encodes alpha2-chimaerin, a Rac guanosine
      triphosphatase-activating protein (RacGAP) signaling protein
    explanation: >-
      Identifies heterozygous CHN1 missense mutations encoding the alpha2-chimaerin
      RacGAP as the cause of the DURS2 form of DRS.
  - reference: PMID:18653847
    reference_title: "Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We found that these are gain-of-function mutations that increase
      alpha2-chimaerin RacGAP activity in vitro.
    explanation: >-
      Establishes the CHN1 variants as gain-of-function, increasing RacGAP
      activity and thereby dysregulating Rac signaling.
  - reference: PMID:28459979
    reference_title: "Ocular congenital cranial dysinnervation disorders (CCDDs): insights into axon growth and guidance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      It can be caused by decreased function of several transcription factors
      critical for abducens motor neuron identity, including MAFB, or by
      heterozygous missense mutations in CHN1
    explanation: >-
      Names reduced MAFB transcription-factor function and CHN1 missense variants
      as causes acting on abducens motor neuron identity and development.
  - reference: PMID:22912401
    reference_title: "Axon guidance in the developing ocular motor system and Duane retraction syndrome depends on Semaphorin signaling via alpha2-chimaerin."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      here we identify candidates to be the Semaphorins (Sema) 3A and 3C, acting
      via the PlexinA receptors. Sema3A/C are expressed in and around the
      developing extraocular muscles and cause growth cone collapse of oculomotor
      neurons in vitro.
    explanation: >-
      Identifies Semaphorin 3A/3C-PlexinA signaling as the axon-guidance cue
      acting upstream of alpha2-chimaerin in ocular motor pathfinding, the
      pathway dysregulated in DRS.
  - reference: PMID:28346224
    reference_title: "Mutant alpha2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      By contrast, Chn1KO/KO mice did not have DRS, and embryos displayed
      abducens nerve wandering distinct from the Chn1KI/KI phenotype.
    explanation: >-
      Demonstrates that DRS arises specifically from CHN1 gain of function (the
      knock-in models DRS) and not loss of function, with ephrin/EphA4 signaling
      acting upstream of alpha2-chimaerin in abducens neurons.
  downstream:
  - target: Abducens Nerve Hypoplasia and Failure to Innervate the Lateral Rectus
    description: >-
      Disrupted abducens motor neuron development leads to hypoplasia of the
      sixth nerve and failure to innervate the lateral rectus muscle.
- name: Abducens Nerve Hypoplasia and Failure to Innervate the Lateral Rectus
  description: >-
    The primary anatomical lesion of DRS is hypoplasia or absence of the
    abducens nerve, which fails to fully innervate the lateral rectus muscle.
    Postmortem and mouse studies establish this as the founding event from which
    the downstream miswiring follows. This denervation underlies the limitation
    of abduction.
  cell_types:
  - preferred_term: abducens motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  biological_processes:
  - preferred_term: abducens nerve development
    term:
      id: GO:0021560
      label: abducens nerve development
    modifier: DECREASED
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The lateral movement anomaly results from failure of the abducens nucleus
      and nerve (cranial nerve VI) to fully innervate the lateral rectus muscle
    explanation: >-
      GeneReviews states the abduction deficit results from failure of the
      abducens nucleus and nerve to innervate the lateral rectus.
  - reference: PMID:27181683
    reference_title: "Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Postmortem studies of DRS have reported abducens nerve hypoplasia and
      aberrant innervation of the lateral rectus muscle by the oculomotor nerve.
    explanation: >-
      Documents the human postmortem pathology of abducens nerve hypoplasia
      underlying DRS.
  - reference: PMID:27181683
    reference_title: "Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we present evidence that the primary cause of DRS is failure of the
      abducens nerve to fully innervate the lateral rectus muscle in early
      development.
    explanation: >-
      Mouse modeling identifies failed abducens innervation of the lateral
      rectus as the primary developmental cause of DRS.
  - reference: PMID:40212284
    reference_title: "Etiology and clinical features of Han Chinese patients with Duane retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 12 of the 14 patients with DRS1 and 9 of the 17 patients with DRS3, the
      abducens nerve was found to be absent in the MRI images, and in 4 of the
      patients with DRS2, the abducens nerve was detected as hypoplasia.
    explanation: >-
      High-resolution MRI in a clinical DRS cohort directly demonstrates absent
      or hypoplastic abducens nerves, confirming the primary anatomical lesion in
      living patients.
  downstream:
  - target: Aberrant Oculomotor Nerve Reinnervation of the Lateral Rectus
    description: >-
      The denervated lateral rectus is secondarily reinnervated by an aberrant
      branch of the oculomotor nerve.
- name: Aberrant Oculomotor Nerve Reinnervation of the Lateral Rectus
  description: >-
    With the abducens nerve absent or hypoplastic, the lateral rectus is
    aberrantly reinnervated by misrouted branches of the oculomotor (third)
    nerve that form near the target extraocular muscles. The lateral rectus is
    thereby wired to fire with the medial rectus during attempted adduction
    rather than during abduction.
  cell_types:
  - preferred_term: aberrant oculomotor motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  - preferred_term: lateral rectus muscle cell
    term:
      id: CL:0000188
      label: cell of skeletal muscle
  biological_processes:
  - preferred_term: ocular motor axon guidance
    term:
      id: GO:0008045
      label: motor neuron axon guidance
    modifier: ABNORMAL
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      globe retraction occurs as a result of abnormal innervation of the lateral
      rectus muscle by the oculomotor nerve (cranial nerve III)
    explanation: >-
      GeneReviews attributes the globe retraction to abnormal oculomotor-nerve
      innervation of the lateral rectus.
  - reference: PMID:27181683
    reference_title: "Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we demonstrate that selectively disrupting abducens nerve development is
      sufficient to cause secondary innervation of the lateral rectus muscle by
      aberrant oculomotor nerve branches, which form at developmental decision
      regions close to target extraocular muscles.
    explanation: >-
      Mouse experiments show that abducens disruption is sufficient to trigger
      secondary aberrant oculomotor reinnervation of the lateral rectus.
  - reference: PMID:18653847
    reference_title: "Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Expression of mutant alpha2-chimaerin constructs in chick embryos resulted
      in failure of oculomotor axons to innervate their target extraocular
      muscles.
    explanation: >-
      Chick-embryo expression of mutant alpha2-chimaerin disrupts oculomotor axon
      targeting of extraocular muscles, modeling the miswiring mechanism.
  - reference: PMID:28346224
    reference_title: "Mutant alpha2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Stalled abducens nerve bundles did not reach the orbit, resulting in
      secondary aberrant misinnervation of the lateral rectus muscle by the
      oculomotor nerve.
    explanation: >-
      The Chn1 knock-in DRS mouse directly demonstrates the core miswiring step:
      abducens axons stall short of the orbit, and the lateral rectus is
      secondarily misinnervated by the oculomotor nerve.
  downstream:
  - target: Co-contraction of the Horizontal Recti and Globe Retraction
    description: >-
      Shared innervation makes the lateral and medial recti co-contract on
      adduction, retracting the globe and limiting horizontal movement.
- name: Co-contraction of the Horizontal Recti and Globe Retraction
  description: >-
    Because the lateral rectus is innervated by the oculomotor nerve along with
    the medial rectus, attempted adduction drives simultaneous contraction
    (co-contraction) of both horizontal recti. The opposing forces pull the
    globe posteriorly into the orbit, producing the characteristic globe
    retraction and narrowing of the palpebral fissure, while abduction remains
    deficient. Upshoot or downshoot of the eye on adduction can result from the
    co-contracting lateral rectus slipping over or under the globe.
  cell_types:
  - preferred_term: horizontal rectus muscle cell
    term:
      id: CL:0000188
      label: cell of skeletal muscle
  evidence:
  - reference: PMID:8310396
    reference_title: "Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the characteristic findings are best explained by a paradoxical
      innervation of the lateral rectus muscle, which subsequently causes a
      cocontraction of the horizontal rectus muscles.
    explanation: >-
      Establishes co-contraction of the horizontal recti from paradoxical lateral
      rectus innervation as the mechanism of the clinical findings.
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the globe retracts into the orbit with attempted adduction, accompanied by
      narrowing of the palpebral fissure
    explanation: >-
      Describes the globe retraction and palpebral fissure narrowing on adduction
      that result from the co-contraction.
phenotypes:
- name: Duane Anomaly
  description: >-
    The defining ocular motility pattern of the syndrome: congenital limitation
    of horizontal eye movement with globe retraction and palpebral fissure
    narrowing on attempted adduction.
  phenotype_term:
    preferred_term: Duane anomaly
    term:
      id: HP:0009921
      label: Duane anomaly
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Duane syndrome is a strabismus condition clinically characterized by
      congenital non-progressive limited horizontal eye movement accompanied by
      globe retraction which results in narrowing of the palpebral fissure.
    explanation: >-
      GeneReviews defines the core Duane anomaly phenotype.
- name: Impaired Ocular Abduction
  description: >-
    Restricted ability to move the affected eye outward, reflecting the deficient
    lateral rectus innervation. Abduction limitation is the most consistent
    feature and predominates in type 1 (Huber I).
  phenotype_term:
    preferred_term: Impaired ocular abduction
    term:
      id: HP:0000634
      label: Impaired ocular abduction
  evidence:
  - reference: PMID:8310396
    reference_title: "Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      retraction of the globe with narrowing of the lid fissure in attempted
      adduction, frequent abduction deficiency with variable limitation to
      adduction, and upshoot and/or downshoot of the affected eye on adduction.
    explanation: >-
      Documents the frequent abduction deficiency characteristic of DRS.
- name: Impaired Ocular Adduction
  description: >-
    Limitation of inward eye movement, variably present and predominating in
    type 2 (Huber II); reflects the aberrant oculomotor co-innervation of the
    lateral rectus that opposes adduction.
  phenotype_term:
    preferred_term: Impaired ocular adduction
    term:
      id: HP:0000542
      label: Impaired ocular adduction
  evidence:
  - reference: PMID:8310396
    reference_title: "Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      frequent abduction deficiency with variable limitation to adduction
    explanation: >-
      Documents the variable adduction limitation seen in DRS, prominent in the
      type 2 pattern.
- name: Palpebral Fissure Narrowing on Adduction
  description: >-
    Narrowing of the eyelid aperture as the globe retracts on attempted
    adduction, a direct consequence of horizontal rectus co-contraction.
  phenotype_term:
    preferred_term: Palpebral fissure narrowing on adduction
    term:
      id: HP:0000661
      label: Palpebral fissure narrowing on adduction
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the globe retracts into the orbit with attempted adduction, accompanied by
      narrowing of the palpebral fissure
    explanation: >-
      Describes the palpebral fissure narrowing accompanying globe retraction on
      adduction.
- name: Upshoot or Downshoot on Adduction
  description: >-
    Sudden vertical (upward and/or downward) deviation of the affected eye on
    attempted adduction, one of the cardinal features of the defining DRS triad
    and a recognized surgical indication. It reflects aberrant co-innervation of
    the horizontal recti (the "leash" phenomenon). No HPO term precisely
    captures upshoot/downshoot on adduction, so the broad "Abnormality of eye
    movement" term is used pending a New Term Request (NTR).
  phenotype_term:
    preferred_term: Upshoot or downshoot of the eye on adduction
    term:
      id: HP:0000496
      label: Abnormality of eye movement
  evidence:
  - reference: PMID:8310396
    reference_title: "Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      retraction of the globe with narrowing of the lid fissure in attempted
      adduction, frequent abduction deficiency with variable limitation to
      adduction, and upshoot and/or downshoot of the affected eye on adduction.
    explanation: >-
      The classic description of DRS lists upshoot and/or downshoot on adduction
      as part of the defining triad.
- name: Strabismus
  description: >-
    Ocular misalignment in primary gaze, present in a substantial proportion of
    affected individuals; esotropia is typical of type 1 and exotropia of type 2.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:31322716
    reference_title: "Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Strabismus in primary position was present in 57 patients (46%), of whom
      39% had esotropia and 61% had exotropia.
    explanation: >-
      Cohort data quantify primary-position strabismus and the esotropia/exotropia
      split in DRS.
- name: Amblyopia
  description: >-
    Reduced vision in the affected eye, occurring in individuals who lack
    binocular vision; a key target of early management.
  phenotype_term:
    preferred_term: Amblyopia
    term:
      id: HP:0000646
      label: Amblyopia
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Individuals with Duane syndrome who lack binocular vision are at risk for
      amblyopia.
    explanation: >-
      GeneReviews identifies amblyopia risk in DRS individuals without binocular
      vision.
- name: Compensatory Abnormal Head Posture
  description: >-
    A habitual face turn toward the affected side adopted to align the eyes and
    preserve binocular single vision, avoiding diplopia.
  phenotype_term:
    preferred_term: Compensatory head turn (anomalous head posture)
    term:
      id: HP:0031705
      label: Compensatory head posture
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Many individuals with Duane syndrome have strabismus in primary gaze but
      can use a compensatory head turn to align the eyes
    explanation: >-
      GeneReviews documents the compensatory head turn used to maintain alignment.
- name: Refractive Error
  description: >-
    Ametropia (refractive error) is common in DRS and contributes to amblyopia
    risk; refractive correction is a mainstay of management.
  phenotype_term:
    preferred_term: Ametropia
    term:
      id: HP:0000539
      label: Abnormality of refraction
  evidence:
  - reference: PMID:31322716
    reference_title: "Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ametropia was found in 94 patients (79%), amblyopia was present in 15
      patients (13%), and 41 patients (34%) underwent surgery.
    explanation: >-
      Cohort data document the high frequency of ametropia (and amblyopia) in DRS.
- name: Sensorineural Hearing Impairment
  description: >-
    In the MAFB-related form, DRS can co-segregate with hearing loss, reflecting
    the role of MAFB in inner-ear development; a dominant-negative MAFB variant
    causes DRS with deafness.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:27181683
    reference_title: "Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report on three heterozygous loss-of-function MAFB mutations
      causing DRS and a dominant-negative MAFB mutation causing DRS and deafness.
    explanation: >-
      Documents the MAFB dominant-negative variant causing DRS together with
      deafness (inner-ear defect).
genetic:
- name: CHN1
  association: Causative
  gene_term:
    preferred_term: CHN1 (alpha2-chimaerin, RacGAP)
    term:
      id: hgnc:1943
      label: CHN1
  evidence:
  - reference: PMID:18653847
    reference_title: "Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Studying families with a variant form of the disorder (DURS2-DRS), we have
      identified causative heterozygous missense mutations in CHN1, a gene on
      chromosome 2q31 that encodes alpha2-chimaerin, a Rac guanosine
      triphosphatase-activating protein (RacGAP) signaling protein
    explanation: >-
      Establishes heterozygous CHN1 gain-of-function missense variants as the
      cause of the DURS2 form of DRS.
- name: MAFB
  association: Causative
  gene_term:
    preferred_term: MAFB (abducens motor neuron identity transcription factor)
    term:
      id: hgnc:6408
      label: MAFB
  evidence:
  - reference: PMID:27181683
    reference_title: "Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report on three heterozygous loss-of-function MAFB mutations
      causing DRS and a dominant-negative MAFB mutation causing DRS and deafness.
    explanation: >-
      Establishes heterozygous loss-of-function MAFB variants (and a
      dominant-negative allele with deafness) as a cause of DRS.
- name: SALL4
  association: Causative
  gene_term:
    preferred_term: SALL4 (Duane-radial ray / Okihiro spectrum)
    term:
      id: hgnc:15924
      label: SALL4
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular genetic testing for a pathogenic variant in CHN1, MAFB, or SALL4
      is most appropriate for those with a positive family history of isolated
      Duane syndrome
    explanation: >-
      GeneReviews lists SALL4 among the genes tested in Duane syndrome; SALL4
      variants underlie the syndromic Duane-radial ray (Okihiro) spectrum.
treatments:
- name: Extraocular Muscle (Strabismus) Surgery
  description: >-
    Surgical recession/transposition of the extraocular muscles to improve
    alignment in primary gaze, reduce a compensatory head posture, and address
    upshoot or downshoot. Surgery does not restore normal abduction but
    rebalances the eyes.
  treatment_term:
    preferred_term: strabismus surgery
    term:
      id: MAXO:0025006
      label: strabismus surgery
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      extraocular muscle surgery to address alignment in primary gaze,
      compensatory head posture, and upshoot or downshoot.
    explanation: >-
      GeneReviews specifies extraocular muscle surgery for alignment, head
      posture, and upshoot/downshoot in DRS.
- name: Amblyopia Therapy
  description: >-
    Occlusion or penalization of the better-seeing eye to treat or prevent
    amblyopia in the affected eye, particularly in individuals lacking binocular
    vision.
  treatment_term:
    preferred_term: occlusion or penalization therapy for amblyopia
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      occlusion or penalization of the better-seeing eye for treatment of
      amblyopia
    explanation: >-
      GeneReviews specifies occlusion/penalization of the better-seeing eye for
      amblyopia management.
- name: Botulinum Toxin Chemodenervation
  description: >-
    Injection of botulinum toxin type A into the horizontal recti (typically the
    ipsilateral medial rectus in esotropic DRS) to weaken co-contraction and
    reduce the primary-position deviation and abnormal head posture. Effect is
    temporary and often requires repeat injection or subsequent surgery, but it
    can improve alignment and quality of life and serve a diagnostic role before
    surgery.
  treatment_term:
    preferred_term: botulinum toxin chemodenervation
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: botulinum toxin type A
      term:
        id: CHEBI:3160
        label: Botulinum toxin type A
  evidence:
  - reference: PMID:35446195
    reference_title: "Duane Retraction Syndrome: The Role of Botulinum Toxin A Injection in Adults and Its Impact on Quality of Life in an Indian Population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There was a significant reduction in ocular deviation in esotropic and
      exotropic Duane retraction syndrome at 10 days (P = .001) and 3 months (P =
      .04) after botulinum toxin injection.
    explanation: >-
      Interventional case series showing botulinum toxin A significantly reduces
      ocular deviation in esotropic and exotropic DRS.
- name: Optical Correction (Spectacles and Prisms)
  description: >-
    Spectacles or contact lenses to correct refractive error, and prism glasses
    (usually in older individuals with mild involvement) to improve a
    compensatory head position.
  treatment_term:
    preferred_term: refractive correction and prism therapy
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:20301369
    reference_title: "Duane Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Spectacles or contact lenses for refractive error; occlusion or
      penalization of the better-seeing eye for treatment of amblyopia; prism
      glasses (usually in older individuals with mild involvement) to improve the
      compensatory head position
    explanation: >-
      GeneReviews specifies refractive correction and prism glasses for DRS
      management.
datasets: []

📚

References & Deep Research

References

10

PMID:20301369

Duane Syndrome.

No top-level findings curated for this source.

PMID:18653847

Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome.

No top-level findings curated for this source.

PMID:27181683

Loss of MAFB Function in Humans and Mice Causes Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects.

No top-level findings curated for this source.

PMID:28459979

Ocular congenital cranial dysinnervation disorders (CCDDs): insights into axon growth and guidance.

No top-level findings curated for this source.

PMID:22912401

Axon guidance in the developing ocular motor system and Duane retraction syndrome depends on Semaphorin signaling via alpha2-chimaerin.

No top-level findings curated for this source.

PMID:28346224

Mutant alpha2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome.

No top-level findings curated for this source.

PMID:8310396

Duane's retraction syndrome.

No top-level findings curated for this source.

PMID:31322716

Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review.

No top-level findings curated for this source.

PMID:40212284

Etiology and clinical features of Han Chinese patients with Duane retraction syndrome.

No top-level findings curated for this source.

PMID:35446195

Duane Retraction Syndrome: The Role of Botulinum Toxin A Injection in Adults and Its Impact on Quality of Life in an Indian Population.

No top-level findings curated for this source.

Deep Research

1

Claude Code ▸

1. Disease Information

claude-haiku-4-5-20251001, claude-sonnet-4-6 17 citations 2026-06-26T05:50:38.725270

1. Disease Information

Overview

Duane Retraction Syndrome (DRS) is a congenital, non-progressive ocular motility disorder characterized by limitation or absence of horizontal eye movements, globe retraction into the orbit, and narrowing of the palpebral fissure on attempted adduction. It is the most common form of congenital cranial dysinnervation disorder (CCDD) and the most frequent cause of congenital paralytic strabismus in humans. The cardinal feature—co-contraction of the medial and lateral recti muscles on attempted adduction—produces the pathognomonic globe retraction and lid-fissure narrowing. DRS results from maldevelopment of the abducens (VI) cranial nerve nucleus and nerve during embryogenesis, with secondary aberrant innervation of the lateral rectus by a misbranched division of the oculomotor (III) nerve.

Key Identifiers

Database	Identifier
MONDO	MONDO:0007473
Orphanet	ORPHA:233
OMIM (DURS1, locus)	126800
OMIM (DURS2, CHN1)	604356
OMIM (DURS3, MAFB ± deafness)	617041
OMIM (Okihiro/DRRS, SALL4)	607323
ICD-10	H50.81
ICD-11	9C80.3
MeSH	D004370

Synonyms and Alternative Names

Duane syndrome
Stilling-Türk-Duane syndrome
Retraction syndrome
Congenital retraction syndrome
Duane retraction syndrome types 1, 2, 3 (DURS1, DURS2, DURS3)
Okihiro syndrome / Duane radial ray syndrome (DRRS) — syndromic SALL4-related form
Wildervanck syndrome (cervico-oculo-acoustic syndrome) — DRS with cervical vertebral fusion and sensorineural hearing loss

Evidence Basis

Information is derived primarily from aggregated disease-level resources (OMIM, GeneReviews, Orphanet, StatPearls), multi-patient retrospective clinical cohort studies, and primary genetics/mechanistic literature. No electronic health record (EHR) population derivation has been required; foundational clinical descriptions come from large case series (e.g., 582-patient amblyopia review, PMID:PMC10797543; 42-patient Chinese cohort, PMID:40212284).

2. Etiology

Disease Causal Factors

DRS is a congenital cranial dysinnervation disorder caused by maldevelopment of the abducens motor neuron pool (cranial nerve VI nucleus) during weeks 4–8 of embryogenesis. The primary pathological event is absence or hypoplasia of the abducens nerve, leading to secondary aberrant innervation of the lateral rectus muscle by a misdirected branch of the inferior division of the oculomotor nerve (CN III). This produces the co-contraction phenotype. The embryologic insult occurs during the critical window of cranial nerve nuclear and axon specification in the developing rhombencephalon (rhombomeres 5–6 for abducens).

In ~10% of cases, a positive family history is present. In the remaining ~90%, cases are sporadic. A definitive molecular etiology is currently identified in only ~2–12% of all DRS cases (more in familial forms), indicating that additional genetic and possibly non-genetic causal factors remain to be discovered.

Genetic Risk Factors

CHN1 (chimerin 1; OMIM:118423) — chromosome 2q31.1 - Encodes α2-chimaerin (alpha2-chimaerin), a Rac GTPase-activating protein (RacGAP) involved in axon guidance cytoskeletal signaling - Pathogenic variants are heterozygous gain-of-function missense mutations that hyperactivate α2-chimaerin RacGAP activity - The landmark paper by Bhatt et al. (2008, PMID:18653847) published in Science identified CHN1 gain-of-function mutations as a cause of DRS (DURS2, OMIM:604356) - Accounts for up to 15% of familial isolated DRS; rare in simplex (sporadic) cases - Incomplete penetrance documented within families; bilateral DRS and vertical movement abnormalities more common - Chick embryo expression of mutant α2-chimaerin causes oculomotor axon stalling and failure to innervate target muscles (PMID:18653847)

MAFB (MAF bZIP transcription factor B; OMIM:608968) — chromosome 20q12 - Encodes MafB, a transcription factor expressed in rhombomeres 5–6 where abducens motor neurons develop - Pathogenic variants are partial loss-of-function / haploinsufficiency; some may act as dominant-negatives - Truncating mutations cause DURS3 (OMIM:617041), which can present with bilateral DRS and sensorineural hearing loss - Accounts for ~4% of familial isolated DRS - MafB knockout mice (Mafb-/-) lack abducens motor neurons; lateral rectus receives oculomotor innervation

SALL4 (sal-like transcription factor 4; OMIM:607343) — chromosome 20q13.2 - Encodes a C2H2 zinc finger transcription factor - Loss-of-function mutations cause Okihiro syndrome / Duane-radial ray syndrome (DRRS, OMIM:607323), a syndromic form of DRS with radial ray anomalies, hearing loss, and other features - Rarely causes isolated familial DRS - Most often presents as bilateral DRS in syndromic context - SALL4 was the first identified Duane syndrome gene

HOXA1 (homeobox A1; OMIM:142955) — chromosome 7p15.3 - Biallelic (autosomal recessive) truncating mutations cause brainstem dysgenesis syndromes (Bosley-Salih-Alorainy syndrome, BSAS; Athabascan brainstem dysgenesis syndrome) that include DRS among other findings - HOXA1 mutations are not a common cause of isolated DRS (isolated sporadic DRS patients do not harbor HOXA1 mutations; PMID:PMC2553396)

Additional DRS-associated genes (rarer): - KIF21A (kinesin family member 21A): primarily associated with CFEOM1 but also implicated in rare DRS cases - TUBB3 (tubulin beta-3): primarily CFEOM3 but overlapping CCDD spectrum - Chromosome 8q13 locus: identified in autosomal dominant DURS1 (OMIM:126800) pedigrees, but causative gene not yet definitively established

Environmental Risk Factors

Thalidomide embryopathy: Thalidomide exposure during early pregnancy (4–8 weeks gestation) has been associated with DRS as part of a broader pattern of cranial nerve maldevelopment; this represents a plausible non-genetic route by directly disrupting brainstem development during the critical cranial nerve specification window
No well-established lifestyle, dietary, or occupational environmental risk factors have been identified for isolated DRS
The sporadic nature of >90% of cases suggests stochastic developmental events, unidentified genetic determinants, or rare environmental exposures

Protective Factors

No genetic or environmental protective factors have been characterized for DRS. As a developmental disorder with embryologic origin in a narrow gestational window, there are no established post-natal modifiable risk factors.

Gene–Environment Interactions

No characterized gene–environment interactions have been described for DRS beyond the thalidomide/HOXA1-pathway hypothesis. The critical developmental window (weeks 4–8 gestation) makes DRS theoretically susceptible to any brainstem teratogen during that period, but no specific GxE studies have been published.

3. Phenotypes

Primary Ocular Phenotypes

Globe Retraction on Adduction (cardinal feature) - Globe retracts into the orbit on attempted adduction due to co-contraction of medial and lateral recti - Present in essentially all cases by definition - HP:0000594 (Retraction of the globe) - Palpebral fissure narrows simultaneously: HP:0000581 (Blepharophimosis) / narrowing of palpebral fissure - Quality of life: disfiguring in moderate-severe cases; motivates surgical referral

Limitation of Abduction (Type I DRS — most common) - Marked or complete restriction of lateral gaze (outward movement) on the affected side - Present in 70–80% of all DRS cases (Type I) - HP:0000568 (Microphthalmia) — use HP:0000640 (Esotropia at primary gaze) and HP:0000638 (Ophthalmoplegia) - More specific HPO: HP:0001489 (Abnormal horizontal eye movement); HP:0000580 (Limitation of ocular abduction) - Severity: marked (near-complete) limitation in Type I - Frequency: virtually 100% in Type I; present to lesser degree in Type III

Limitation of Adduction (Type II DRS) - Marked or complete restriction of medial gaze (inward movement) - Present in 7–10% of cases (Type II) - HP:0001489; HP:0001491 (Limitation of ocular adduction) - Associated exotropia at primary gaze: HP:0000577 (Exotropia)

Combined Abduction and Adduction Limitation (Type III DRS) - Both ab- and ad-duction restricted - Present in 10–25% of cases (Type III) - HPO: HP:0001489 - Primary position alignment variable (orthotropia, esotropia, or exotropia)

Esotropia - Most common primary position deviation, especially in Type I - Mean preoperative esotropia in Type I: ~33 prism diopters (PMID:40212284) - HP:0000565 (Esotropia) - Frequency: FREQUENT in Type I

Exotropia - Characteristic of Type II; also seen in some Type III cases - Mean preoperative exodeviation Type II: ~51 prism diopters (PMID:40212284) - HP:0000577 (Exotropia)

Upshoot / Downshoot on Adduction - Vertical deviation of the globe (upward or downward) when attempting adduction, due to "leash effect" of the tethered lateral rectus - Upshoot more common than downshoot - HP:0007902 (Upbeat nystagmus) — note: dedicated HPO term for upshoot of the globe in adduction - Frequency: OCCASIONAL to FREQUENT depending on series - Severity: can be functionally and cosmetically significant

Compensatory Head Posture / Abnormal Head Position - Face turns toward the affected eye to use the uninvolved field of binocular vision - Present in majority of symptomatic patients - HP:0000570 (Abnormal head movements) / abnormal head posture - One surgical indication is >15° head turn - Frequency: FREQUENT in patients with primary position deviation

Amblyopia - Overall prevalence: 20.1% of all DRS patients (582-patient series) - By type (unilateral): Type I 16.4%, Type II 14.9%, Type III 19.5%, Type IV 60% - Bilateral DRS carries higher amblyopia risk: 36.5% vs. 18.5% for unilateral (P<0.001) - Predominantly strabismic amblyopia (62.4%), followed by combined-mechanism (32.5%), and refractive (5.1%) - HP:0000508 (Ptosis); HP:0000486 (Strabismus) — for the strabismus-driven amblyopia - HP:0000545 (Myopia); HP:0000540 (Hypermetropia); HP:0000497 (Amblyopia) - Severity distribution: mild (14.6%), moderate (2.9%), severe (2.6%) - Onset: early childhood; treatment window critical in first 7–10 years

Refractive Errors - Hyperopia: most common (31.3% of unilateral cases); prevalence higher in Type I (35.1%) - Myopia: 16.2% of unilateral patients; more frequent in Type III (23.7%) - Astigmatism: affected eye shows significantly greater cylindrical power vs. non-affected eye (-0.70 ± 0.91 vs. -0.52 ± 0.84 diopter, P<0.001) - Anisometropia: 12.9% of all patients; 37.6% of amblyopic patients had concurrent anisometropia - HP:0000545 (Myopia); HP:0000540 (Hypermetropia); HP:0000483 (Astigmatism); HP:0007720 (Anisometropia)

Nystagmus (uncommon) - Reported in 4/42 patients (9.5%) in one cohort (PMID:40212284) - HP:0000639 (Nystagmus) - Frequency: OCCASIONAL

Crocodile Tears (Gustatory Lacrimation) - Aberrant lacrimation on eating due to misdirected autonomic fibers - Rare; reported as associated anomaly - HP:0025545 (Crocodile tears)

Non-Ocular Phenotypes (Syndromic Forms)

Sensorineural Hearing Loss (MAFB/DURS3; also Wildervanck) - MAFB variants associated with bilateral DRS and possible sensorineural hearing loss; inner ear anomalies documented - HP:0000407 (Sensorineural hearing loss)

Radial Ray Anomalies (SALL4/Okihiro syndrome) - Hypoplastic or absent thumbs, radial dysplasia, carpal bone fusions - HP:0002984 (Hypoplasia of the radius); HP:0001171 (Split hand)

Cervical Vertebral Fusion (Wildervanck syndrome / Klippel-Feil) - HP:0002800 (Klippel-Feil syndrome)

Cardiac Defects, Renal Anomalies, Ear Anomalies (approximately 30% of all DRS have non-ocular features) - HP:0001627 (Abnormal heart morphology); HP:0000077 (Kidney abnormality)

4. Genetic/Molecular Information

Causal Genes

Gene	Locus	HGNC	OMIM	Mechanism	DRS Association
CHN1	2q31.1	HGNC:1943	118423	Gain-of-function missense	DURS2 (604356), isolated familial DRS
MAFB	20q12	HGNC:6853	608968	Haploinsufficiency / partial LoF	DURS3 (617041), DRS ± deafness
SALL4	20q13.2	HGNC:15924	607343	Loss-of-function	Okihiro/DRRS (607323), syndromic DRS
HOXA1	7p15.3	HGNC:5099	142955	Biallelic truncating (AR LoF)	Brainstem dysgenesis syndromes with DRS
8q13 locus	8q13	—	126800	Unknown	DURS1, dominant familial

Pathogenic Variants

CHN1 gain-of-function variants: - All pathogenic CHN1 variants are heterozygous missense mutations that disrupt the autoinhibited closed conformation of α2-chimaerin protein, increasing its membrane translocation and RacGAP activity - Identified variants from literature: p.Ile126Thr (c.377T>C), p.Glu220Gly (c.659A>G), p.Phe213Val (c.637T>G in a large Chinese family, PMID:PMC7531002) - Variant classification: Pathogenic (ACMG) for familial cases; evidence: co-segregation, functional in vitro and in vivo (chick embryo expression) - Variant type: Missense; germline; heterozygous - Population frequency: Very rare; absent from large general-population cohorts (gnomAD) at comparable allele frequency - Functional consequence: Gain of function — hyperactivated RacGAP activity; does NOT cause disease through LoF (Chn1 KO mice do NOT develop DRS) - Somatic/germline: Germline

MAFB loss-of-function variants: - Truncating variants (nonsense, frameshift) and missense variants with functional evidence - Mechanism: haploinsufficiency disrupts abducens nucleus development during rhombomere 5–6 specification - Functional consequence: Loss of function / partial dominant negative

SALL4 loss-of-function variants: - Predominantly truncating (nonsense, frameshift), intragenic deletions - Cause DRRS/Okihiro syndrome; variable expressivity - Functional consequence: Loss of function (zinc finger transcription factor haploinsufficiency)

Molecular Yield in DRS

Familial isolated DRS: CHN1 ~15%, MAFB ~4%, SALL4 rare; total ~20% molecular yield in familial cases
Sporadic isolated DRS: >98% lack an identified molecular etiology (GeneReviews, PMID:NBK1190)
42-patient Han Chinese cohort: 11% (5/42) identified pathogenic variants (PMID:40212284)

Modifier Genes

No modifier genes have been definitively characterized for DRS. Variable expressivity and incomplete penetrance in CHN1-related DRS families suggest the existence of modifying genetic or environmental factors, but these remain uncharacterized.

Epigenetic Information

No DRS-specific epigenetic findings (DNA methylation, histone modifications) have been published. DRS is a developmental structural defect rather than a condition driven by postnatal epigenetic dysregulation.

Chromosomal Abnormalities

Rare chromosomal microdeletions/duplications involving the DRS-associated loci have been reported in case series: - Duplication of chromosome 8q12 has been associated with DRS and developmental delay (PMID: Nature/EJHG 2011) - 1p36 deletion syndrome can include DRS as a feature (PMID:PMC7487539) - These are rare and typically associated with additional dysmorphic features and intellectual disability

5. Environmental Information

Environmental Factors

Thalidomide: Thalidomide embryopathy is the best-characterized environmental cause of DRS. Thalidomide taken during weeks 4–8 of gestation (the sensitive period for brainstem cranial nerve development) can cause DRS as part of a pattern of cranial nerve dysinnervation, along with limb defects and ear anomalies
No other environmental chemicals, radiation, pollution, or occupational exposures have been definitively linked to DRS in population studies

Infectious Agents

No infectious agents have been identified as causes of DRS.

Lifestyle Factors

No lifestyle factors (diet, exercise, smoking, alcohol) have been linked to DRS risk. As a congenital condition with embryologic origin, preventable environmental exposure during the critical developmental window (weeks 4–8 gestation) is the only modifiable risk factor.

6. Mechanism / Pathophysiology

Overview of Pathological Cascade

The core pathophysiological cascade in DRS is:

Maldevelopment of abducens motor neurons (CN VI nucleus/nerve) → Absence or severe hypoplasia of the abducens nerve → Lateral rectus muscle receives no (or reduced) abducens innervation → Secondary aberrant innervation of the lateral rectus by a misdirected branch of the inferior division of the oculomotor nerve (CN III) → Paradoxical co-contraction of medial and lateral recti during attempted adduction → Globe retraction + palpebral fissure narrowing + restricted horizontal motility

This has been confirmed by: 1. Autopsy studies: Matteucci (1946) first reported hypoplastic abducens nucleus; Hotchkiss et al. (1980) confirmed absent CN VI nucleus/nerve in two autopsy cases with aberrant CN III innervation of lateral rectus 2. Electromyography: Simultaneous co-activation of lateral and medial rectus EMG signals on attempted adduction 3. High-resolution MRI neuroimaging: Demonstrates absent or hypoplastic abducens nerve in 86% of Type I DRS cases and 53% of Type III cases on MRI (PMID:40212284); lateral rectus muscle structurally abnormal; small oculomotor and optic nerves in some cases 4. Mouse genetic models: Chn1 knock-in mice display stalled abducens nerve axons that fail to reach the orbit; lateral rectus muscle subsequently receives aberrant oculomotor innervation (PMID:PMC5409791)

Molecular Pathways

α2-Chimaerin / Rac1 / Cytoskeletal Signaling Pathway

The best-characterized molecular pathway in DRS involves α2-chimaerin (encoded by CHN1):

α2-chimaerin is a RacGAP (Rac GTPase-activating protein) that inactivates Rac1 GTPase, thereby regulating cytoskeletal dynamics (actin polymerization) essential for axon growth cone navigation
In normal development, α2-chimaerin functions downstream of multiple axon guidance receptor systems, including EphA4/ephrin, Neuropilin1/Semaphorin, and TrkB signaling
CHN1 gain-of-function mutations disrupt the autoinhibited closed conformation of α2-chimaerin → increased membrane translocation and constitutive RacGAP hyperactivation → excessive Rac1 inactivation → growth cone collapse and stalling specifically in abducens motor neurons
In chick embryos, expression of hyperactive mutant α2-chimaerin causes failure of oculomotor axons to innervate target extraocular muscles (PMID:18653847)

Semaphorin/PlexinA → α2-Chimaerin Signaling

Semaphorin 3A (Sema3A) and Semaphorin 3C (Sema3C) are expressed in and around the developing extraocular muscles
They act as axon guidance cues signaling through PlexinA receptors on abducens neurons
This Semaphorin/PlexinA signaling operates upstream of α2-chimaerin to regulate growth cone navigation
"Axon guidance in the developing ocular motor system and Duane retraction syndrome depends on Semaphorin signaling via alpha2-chimaerin" (PMID:22912401, PNAS 2012)
Sema3A/C cause growth cone collapse of oculomotor neurons in vitro via α2-chimaerin

EphA4/Ephrin Bidirectional Signaling

EphA4 is expressed on abducens motor neuron axons
Mutant α2-chimaerin engages EphA4-mediated bidirectional ephrin signaling (both forward EphA4 → ephrin signaling AND reverse ephrin → EphA4 signaling) in abducens neurons specifically
EphA4 KO mice display abducens nerve wandering/defasciculation, distinct from the DRS stalling phenotype
Chn1KI/KI EphA4KO/KO double mutants showed that abducens neurons uniquely use bidirectional ephrin signaling, while cervical spinal motor neurons use only forward ephrin signaling and trochlear neurons use no ephrin signaling — explaining the selective abducens vulnerability (PMID:28346224, JCI 2017)

MAFB / Rhombomere Specification Pathway

MafB is a transcription factor expressed in rhombomeres 5 and 6 during the critical period of abducens motor neuron specification in the developing brainstem
MafB loss of function → failure of abducens motor neurons to specify or survive → abducens nucleus absent → identical secondary lateral rectus misdirection pattern as seen in CHN1-related DRS
Mafb KO mice lack abducens motor neurons; lateral rectus receives oculomotor nerve innervation

SALL4 / Transcriptional Regulation of Branchiomotor Neuron Development

SALL4 encodes a zinc finger transcription factor required for normal abducens motor neuron development
Loss-of-function mutations in SALL4 cause broader brainstem dysinnervation (DRRS/Okihiro syndrome) affecting CN VI as well as causing radial ray and inner ear abnormalities

Cellular Processes Involved

Axon guidance / pathfinding (GO:0007411 — axon guidance)
Motor neuron differentiation / specification (GO:0045664 — regulation of motor neuron differentiation)
Cytoskeletal organization in growth cone (GO:0048666 — neuron development; GO:0045773 — positive regulation of axon extension)
Growth cone collapse (GO:0007413 — axonal fasciculation)
Neuromuscular junction formation (GO:0007528)
Brainstem neurogenesis in rhombomeres 5–6 (GO:0022008 — neurogenesis)

Cell Types Involved

Abducens motor neurons (CN VI nucleus, pons; CL:0008033 — motor neuron)
Oculomotor neurons (CN III nucleus, midbrain; CL:0008033)
Lateral rectus muscle fibers — myofibers that become aberrantly innervated and undergo secondary fibrosis (CL:0000187 — muscle fiber)
Medial rectus muscle fibers — undergo hypertrophy from overuse (CL:0000187)
Rhombomere 5–6 neural progenitors — site of abducens nucleus specification

Histopathology / Tissue-Level Findings

Autopsy and surgical biopsy studies of the lateral rectus in DRS reveal: - Reduced number of muscle fibers replaced by dense collagenous tissue - Remaining fibers are often atrophic with variable fiber size - Some fibers show central nuclei (indicative of chronic myopathic change) - Irregular and sparse neuromuscular junctions by histochemistry - No classical neurogenic atrophy (consistent with paradoxical innervation rather than complete denervation) - Medial rectus shows hypertrophy from overuse

Subcellular / Protein Dysfunction

α2-Chimaerin protein: DRS-causing missense variants disrupt the autoinhibited "closed" conformation → increased membrane translocation → hyperactivated GTPase-activating function → excessive Rac1 inactivation
MafB transcription factor: Haploinsufficiency reduces transcriptional activation of abducens motor neuron specification genes
SALL4 zinc finger protein: Loss-of-function disrupts brainstem transcriptional programs governing CN VI development

Biochemical Abnormalities

No primary biochemical abnormalities (enzyme deficiencies, metabolite accumulation) characterize DRS. The pathology is purely structural/developmental.

7. Anatomical Structures Affected

Primary Nervous System Structures

Structure	Description	UBERON
Abducens nerve (CN VI)	Absent or hypoplastic; the primary lesion	UBERON:0001647
Abducens nucleus	Absent or reduced in neuron number (pons, rhombomere 5–6)	UBERON:0002682
Oculomotor nerve (CN III)	Provides aberrant innervation branch to lateral rectus; inferior division typically involved	UBERON:0001643
Lateral rectus muscle	Aberrantly innervated; secondarily fibrotic	UBERON:0006312
Medial rectus muscle	Hypertrophic from overuse	UBERON:0006311
Pons (brainstem)	Contains abducens nucleus; site of primary developmental defect	UBERON:0000988

Secondary Anatomical Structures

Structure	Description	UBERON
Orbit / orbital cavity	Globe retraction occurs here	UBERON:0001693
Palpebral fissure	Narrows on adduction	UBERON:0001715
Superior/inferior oblique muscles	Affected in upshoot/downshoot and some CHN1 cases	UBERON:0006314/UBERON:0006315
Cochlea / inner ear	Affected in MAFB-related DRS with deafness	UBERON:0001690
Radius / radial rays	Affected in SALL4/Okihiro syndrome	UBERON:0001423
Cervical vertebrae	Affected in Wildervanck syndrome	UBERON:0002399

Lateralization

Unilateral in ~80–90% of cases: left eye affected more commonly (60–72% of unilateral cases)
Bilateral in 10–20%: more common with CHN1, MAFB, and SALL4 variants than sporadic cases
In bilateral cases, the two eyes may be asymmetric in severity and type

8. Temporal Development

Onset

Congenital: DRS is present from birth; the structural developmental defect occurs during weeks 4–8 of gestation
Typically detected in early childhood when parents notice head posture, eye deviation, or asymmetric eye movements; may be detected at newborn screening ophthalmological examination
HP:0003577 (Congenital onset)
Onset pattern: chronic / present at birth; non-progressive

Disease Course

Non-progressive: The ocular motility restriction does not worsen over time; the condition is stable throughout life
Compensatory head posture and visual acuity tend to remain stable
Amblyopia can develop or worsen if not treated during the critical visual development window (roughly first 7–10 years of life)
No episodic, relapsing-remitting, or fluctuating course

Progression Pattern

Stable: No known progressive deterioration of abducens deficiency or globe retraction
However, secondary changes (fibrosis of lateral rectus, head posture muscle tightness) can worsen if untreated
Amblyopia must be addressed before the critical period closes (~age 7–10)

Critical Periods

Critical embryological window: weeks 4–8 gestation (abducens nucleus specification in rhombomere 5–6)
Visual critical period: birth through approximately age 7–10 for amblyopia treatment

9. Inheritance and Population

Epidemiology

Prevalence: 0.1–0.7 per 1,000 live births (approximately 1:1,000 to 1:10,000); Orphanet lists ~1:1,000
Strabismus proportion: Accounts for 1–5% of all strabismus cases in ophthalmology practice
Sex ratio: Female predominance — 56% female in unilateral series (GeneReviews); 2.5:1 to 6:1 female:male reported in some series; 57.6% female in 582-patient amblyopia review
Laterality: Left eye affected in 60–72% of unilateral cases; bilateral in 10–20%
Type distribution: Type I ~70–80%; Type II ~7–10%; Type III ~10–25%

Inheritance Pattern

Autosomal dominant (AD): Most familial isolated DRS (CHN1, MAFB, SALL4 genes)
Autosomal recessive (AR): HOXA1-related brainstem dysgenesis syndromes with DRS
Sporadic: >90% of all DRS cases; no family history in the majority
Family history present in approximately 10% of cases
When genetic diagnosis is established, offspring of affected individuals with AD variants have 50% recurrence risk

Penetrance and Expressivity

Incomplete penetrance documented in CHN1-related DRS families; obligate carriers may be unaffected
Variable expressivity: Even within the same family with the same CHN1 variant, affected members may differ in type (I vs. III), laterality, and severity
MAFB variants: variable expressivity; associated deafness not invariable

De Novo Variants

De novo pathogenic variants in CHN1, MAFB, or SALL4 identified in some simplex cases
Most simplex/sporadic cases (>98%) have no identifiable molecular etiology

Founder Effects / Population Genetics

No well-characterized founder mutations for DRS in specific ethnic groups have been published
CHN1 variants are found across diverse ethnic backgrounds (European, Chinese, Middle Eastern)
HOXA1 founder mutations have been identified in Saudi Arabian (Bosley-Salih-Alorainy syndrome) and Athabascan Native American populations for syndromic DRS with brainstem dysgenesis

Carrier Frequency

Not applicable for the dominant and sporadic forms
For HOXA1-AR forms in specific populations with founder mutations: elevated carrier frequency within those populations

Geographic Distribution

DRS occurs worldwide without geographic restriction
No endemic areas; prevalence appears relatively uniform across populations studied
HOXA1 AR forms show founder effect clustering in specific geographic communities (Arabian Peninsula, North America Athabascan)

10. Diagnostics

Clinical Diagnosis

DRS is fundamentally a clinical diagnosis established by ophthalmological examination demonstrating the characteristic triad: 1. Limited abduction and/or adduction in the affected eye(s) 2. Globe retraction with palpebral fissure narrowing on attempted adduction (pathognomonic) 3. Congenital, non-progressive history

Key clinical tests: - Prism cover testing: Measures primary position horizontal deviation (esotropia or exotropia) - Ocular motility assessment (versions and ductions): Documents extent of abduction/adduction limitation - Forced duction testing (FDT): Demonstrates mechanical restriction of the lateral rectus; differentiates from isolated CN VI palsy - Hirschberg / Krimsky test: For strabismus angle measurement - Cycloplegic refraction: 30–70% of patients have hypermetropia >1.5D; cycloplegic refraction essential in all pediatric patients

Electromyography (EMG): - Demonstrates simultaneous co-activation of medial and lateral rectus on attempted adduction (confirming paradoxical innervation) - Useful for atypical cases; rarely needed for routine diagnosis

High-Resolution MRI (Neuroimaging): - Demonstrates absent or hypoplastic abducens nerve in the majority of cases - Type I DRS: absent abducens nerve in 86% (12/14) on MRI (PMID:40212284) - Type II DRS: hypoplastic abducens nerve in all 4/4 imaged patients - Type III DRS: absent abducens nerve in 53% (9/17) on MRI - Differentiates DRS from congenital CN VI palsy: lateral rectus atrophy is characteristic of chronic CN VI palsy (denervation) but NOT of DRS (paradoxically innervated) - DTI (diffusion tensor imaging): absent projective fibers in the medial longitudinal fasciculus in patients lacking visible abducens nerve - MRI findings in DURS2 (JNO 2024)

Visual Acuity Assessment: - Corrected distance visual acuity significantly worse in affected eye in unilateral DRS (0.07 ± 0.17 vs. 0.03 ± 0.11 logMAR, P<0.001) - Essential for amblyopia detection

Genetic Testing

Indications for molecular testing: - Positive family history of isolated DRS - Bilateral DRS (higher yield for CHN1, MAFB) - Type I or III DRS in familial context - Associated sensorineural hearing loss (suggests MAFB) - Associated radial ray anomalies (indicates SALL4 / Okihiro syndrome) - Suspicion of brainstem dysgenesis syndrome (HOXA1)

Testing approaches (in order of appropriateness): 1. Single-gene sequencing of CHN1, MAFB, or SALL4 for familial cases with clear phenotype 2. Multigene panel including CHN1, MAFB, SALL4, HOXA1, KIF21A, TUBB3 for atypical or syndromic presentations 3. Exome sequencing (WES) or genome sequencing (WGS): For cases without diagnosis after targeted testing; particularly useful for syndromic forms or novel presentations 4. Chromosomal microarray (CMA): When dysmorphic features or intellectual disability suggest chromosomal etiology (e.g., 1p36 deletion, 8q12 duplication) 5. Karyotyping: Low yield for isolated DRS; reserved for dysmorphic syndrome suspicion

Diagnostic yield: >98% of sporadic isolated DRS cases have no identified molecular etiology. Yield is highest (~20%) in multiplex families with bilateral DRS.

Differential Diagnosis

Conditions to distinguish from DRS: - Congenital CN VI (abducens) palsy: No globe retraction; lateral rectus atrophy on MRI; may partially improve (DRS never improves) - Congenital fibrosis of extraocular muscles (CFEOM): Bilateral ptosis and restricted upgaze; different pattern of restriction - Möbius syndrome: Bilateral facial nerve (CN VII) palsy + CN VI involvement; no globe retraction - Brown syndrome: Superior oblique tendon sheath syndrome; restricted elevation in adduction; no globe retraction - Congenital ocular motor apraxia (COMA): Head-thrust saccades; different motility pattern

Screening

No population-based newborn screening program exists for DRS
Opportunistic ophthalmological screening in infancy/early childhood recommended
Cascade screening of first-degree relatives when pathogenic variant identified in a family
Prenatal testing: Available once pathogenic variant identified in family; preimplantation genetic testing (PGT) possible

11. Outcome / Prognosis

Life Expectancy

DRS does not affect life expectancy. No excess mortality is attributable to isolated DRS.

Visual Prognosis

Non-progressive: Ocular motility restriction and globe retraction remain stable throughout life; no spontaneous resolution
Visual acuity: Normal if amblyopia does not develop; binocular function often well-preserved with compensatory head posture
Amblyopia: The main threat to visual outcome; occurs in 20.1% of DRS patients overall; mild in majority (85 cases / 14.6% were mild; 2.9% moderate; 2.6% severe)
With appropriate amblyopia treatment and surgical alignment, most patients achieve good functional vision

Surgical Outcomes

Surgical alignment goals: residual horizontal deviation <10 prism diopters
DRS Type I (medial rectus recession): Mean postoperative deviation 3.3 ± 2.4 prism diopters (from ~33 preoperative); achieved in 35/35 surgical patients in one cohort (PMID:40212284)
Surgery improves head posture and cosmesis but cannot restore normal ocular motility; residual limitations persist
Botulinum toxin: significant but short-term esotropia reduction (~26 → ~14 prism diopters at 6 months); 46.5% of patients who received toxin subsequently required surgery

Morbidity

Cosmetic impact from abnormal head posture and globe retraction
Secondary musculoskeletal issues (neck stiffness, torticollis) from chronic compensatory head posture
Psychosocial impact, particularly in school-aged children and adults

Quality of Life

Botulinum toxin for DRS in adults significantly improved quality of life measures in an Indian population (PMID:35446195)
Surgical alignment improves QoL by correcting head posture and improving cosmesis
Most patients with adequate treatment maintain good functional binocular vision and lead normal lives

Prognostic Factors

Amblyopia risk greatest when: bilateral DRS, Type IV, early onset before treatment, high anisometropia
Bilateral DRS: Higher amblyopia rate (36.5% vs. 18.5% unilateral; P<0.001)
Degree of primary position deviation: Larger deviation = higher amblyopia risk + stronger surgical indication
Type: Type I has highest surgical volume due to esotropia and head posture burden

12. Treatment

Non-Surgical Interventions

Observation - Mild DRS without significant head posture, deviation, or amblyopia risk: observation + monitoring - MAXO:0000950 (supportive care)

Spectacles / Contact Lenses - Correct refractive errors (hypermetropia prevalent); may reduce deviation and amblyopia risk - MAXO:0000042 (optical correction) / use NCIT:C49236 (Therapeutic Procedure)

Amblyopia Treatment - Occlusion therapy (patching) of the fellow eye: cornerstone of amblyopia management - Penalization (atropine drops to fellow eye): alternative or adjunct - Must be initiated before closure of visual critical period (~age 7–10) - MAXO:0000466 (vision care) / NCIT:C15634 (Occlusion Therapy)

Prism Correction - Base-out prisms for esotropic DRS: may reduce compensatory head posture; rarely completely corrective - Diagnostic role before surgery

Botulinum Toxin Type A (BtxA) Injection - Injected into the ipsilateral medial rectus (esotropic DRS Type I) to reduce co-contraction and primary deviation - Short-term efficacy: significant esotropia reduction (mean 26.27 → 13.5 prism diopters at 6 months; success rate 75% in one series) - Most patients require repeat injections or subsequent surgery; results not durable long-term - Diagnostic role: if botulinum toxin improves head posture and reduces diplopia, surgery is more likely to succeed - In children up to age 2–3: may delay or reduce extent of surgery needed - MAXO:0000026 (botulinum toxin injection); therapeutic agent: CHEBI:85993 (botulinum toxin type A) - PMID:20230203 (diagnostic use); PMID:23477770 (children ≤3 years); PMID:35446195 (adult QoL outcomes)

Surgical Treatment (Primary Intervention)

Surgery is indicated for: (1) significant primary position deviation; (2) marked abnormal head posture (>15°); (3) disfiguring globe retraction; (4) severe upshoots/downshoots

Surgical procedures:

Esotropic DRS (Type I): - Unilateral medial rectus recession: Corrects up to ~20 prism diopters; first-line for modest esotropia + head posture - Bilateral medial rectus recession: For larger deviations (>20 PD) - Medial rectus recession + lateral rectus recession (same eye): For combined co-contraction with significant retraction - Vertical rectus muscle transposition (Hummelsheim, Jensen procedures): For augmentation - Superior rectus transposition (SRT): Transposition with reduced anterior segment ischemia risk vs. vertical rectus split - MAXO:0000004 (surgical procedure); NCIT:C16186 (Orthopedic Surgical Procedure)

Exotropic DRS (Type II): - Lateral rectus recession: Primary procedure - Periosteal fixation of lateral rectus: For large exotropia with globe tethering

Globe retraction / upshoots / downshoots (Type III / all types): - Y-splitting of lateral rectus muscle: Splits the lateral rectus into two halves sutured superiorly and inferiorly to distribute tension and reduce co-contraction - Periosteal fixation with or without recession - Vertical rectus recession: For refractory upshoots/downshoots

Surgical outcomes: - Corrects primary position deviation and abnormal head posture in most cases - Cannot restore normal abduction; residual limitation persists - Complication: consecutive exotropia (overcorrection); induced vertical deviations post-transposition (6–30%); globe retraction worsening (rare); anterior segment ischemia (rare, with multiple muscle procedures)

Experimental / Investigational Treatments

No gene therapy or novel pharmacological treatments are in clinical trials for DRS at present
Stem cell approaches to CN VI neuron regeneration are theoretical/preclinical only
No registered clinical trials (ClinicalTrials.gov) specifically for DRS therapeutics are currently active

13. Prevention

Primary Prevention

No established primary prevention exists for DRS as a developmental cranial nerve condition. - Avoidance of thalidomide during pregnancy: Relevant only for the rare environmentally-triggered subtype; thalidomide is now tightly regulated - General prenatal care and avoidance of known teratogens during weeks 4–8 gestation are advisable but not DRS-specific

Secondary Prevention (Early Detection)

Early ophthalmological screening in infancy: Detects DRS before amblyopia becomes irreversible
Cascade screening of at-risk relatives: When a pathogenic CHN1, MAFB, or SALL4 variant is identified in a family, first-degree relatives should receive targeted molecular testing and early ophthalmological evaluation (within first year of life)
MAXO:0000079 (genetic counseling)

Tertiary Prevention (Complication Prevention)

Amblyopia treatment (occlusion/penalization) before age 7–10: prevents visual acuity loss
Surgical alignment correction: Prevents secondary musculoskeletal complications (torticollis, neck contracture) from chronic compensatory head posture
Refractive correction: Spectacles/contact lenses reduce anisometropic amblyopia risk

Genetic Counseling

MAXO:0000079 (genetic counseling)
Autosomal dominant forms: 50% recurrence risk to offspring of affected parent when pathogenic variant identified
Sporadic cases: Low recurrence risk (~1%) to siblings; germline mosaicism should be discussed
Prenatal testing (CVS, amniocentesis) and preimplantation genetic testing (PGT) available once family variant identified
DNA banking recommended for families without identified molecular etiology
NSGC (National Society of Genetic Counselors) referral recommended for all familial cases

14. Other Species / Natural Disease

DRS as an isolated naturally-occurring condition has not been described in non-human species outside of genetic models.

Taxonomy: Disease as described is specific to Homo sapiens (NCBITaxon:9606)
No veterinary DRS analogues are reported in companion animals or wildlife under natural conditions
The genetic models described below are the only known animal DRS equivalents

15. Model Organisms

Mouse Models

Chn1 KI (Knock-In) Mouse — Primary DRS Model - Genotype: Chn1 L20F/L20F knock-in (homozygous gain-of-function mutation modeling familial CHN1-DRS) - Phenotype recapitulation: Whole-embryo imaging reveals stalled abducens nerve growth in hindbrain mesenchyme; stalled bundles do not reach the orbit → lateral rectus muscle receives secondary aberrant oculomotor innervation → DRS phenotype (PMID:PMC5409791) - Key finding: Chn1 KO/KO (loss-of-function) mice do NOT develop DRS; abducens nerve wanders but does not stall → confirms CHN1 gain-of-function mechanism - Additional features: Trochlear nerve guidance abnormalities and first cervical spinal nerve guidance defects observed in Chn1 KI/KI mice, consistent with rare vertical movement abnormalities in CHN1-related human DRS

EphA4 Knockout Mouse - Genotype: EphA4 KO/KO - Phenotype: Abducens nerve defasciculation and wandering; distinct from the stalling phenotype in CHN1 KI mice - Utility: Reveals EphA4 as upstream regulator of abducens axon guidance; Chn1 KI × EphA4 KO double mutants demonstrated bidirectional ephrin signaling specificity in abducens vs. other motor neuron pools (PMID:28346224)

Mafb Knockout Mouse - Genotype: Mafb KO/KO - Phenotype: Abducens motor neurons fail to develop; lateral rectus receives oculomotor nerve innervation — recapitulates the secondary aberrant innervation seen in human DRS - Utility: Demonstrates MafB requirement for abducens motor neuron specification in rhombomeres 5–6; validates MAFB-related DRS mechanism

Map1b × KIF21A Double Heterozygous Mouse - Used in CFEOM studies; increased penetrance of oculomotor pathology in double heterozygotes - Indirect relevance to DRS as part of CCDD spectrum

Chick Embryo Model

Overexpression of hyperactive mutant α2-chimaerin constructs in chick embryos causes oculomotor axon stalling and failure to innervate target extraocular muscles (PMID:18653847)
Knockdown of α2-chimaerin in chick embryos produces branching defects and stalling
Used to study Semaphorin 3A/3C → PlexinA → α2-chimaerin signaling in oculomotor axon pathfinding (PMID:22912401)

Model Limitations

Mouse abducens anatomy: Rodent abducens nerve anatomy differs from human; complete functional validation of motility deficits requires electrophysiological and imaging approaches not directly analogous to clinical ocular motility testing
Gain-of-function specificity: The mouse Chn1 KI model recapitulates CHN1-related DRS (DURS2) but does not model the molecular cause of the majority of sporadic cases, which remain genetically uncharacterized
Secondary fibrosis: Long-term fibrosis of the lateral rectus seen in human DRS may not be fully recapitulated in mouse embryo models studied at embryonic/neonatal stages

Databases and Resources

MGI (Mouse Genome Informatics): Chn1, Mafb, EphA4 allele records
IMSR (International Mouse Strain Resource): CHN1 knock-in strains
ZFIN: Zebrafish α2-chimaerin knockdown studies (exploratory)
Alliance of Genome Resources: Comparative genomics, CHN1 orthologues

Summary Table of Key Ontology Terms

HPO Terms (Phenotypes)

Phenotype	HPO Term
Globe retraction	HP:0000594
Esotropia	HP:0000565
Exotropia	HP:0000577
Amblyopia	HP:0000497
Limitation of ocular motility	HP:0000597
Abnormal head position/head tilt	HP:0000570
Nystagmus	HP:0000639
Strabismus (general)	HP:0000486
Sensorineural hearing loss	HP:0000407
Radial ray aplasia	HP:0002984
Myopia	HP:0000545
Hypermetropia	HP:0000540
Astigmatism	HP:0000483
Anisometropia	HP:0007720
Congenital onset	HP:0003577
Palpebral fissure narrowing	HP:0045025

GO Terms (Biological Processes)

Process	GO Term
Axon guidance	GO:0007411
Motor neuron differentiation	GO:0045664
Regulation of axon extension	GO:0045773
Neuromuscular junction development	GO:0007528
Cytoskeletal organization	GO:0007010
Rac protein signal transduction	GO:0016601
Semaphorin-plexin signaling	GO:0097490

CL Terms (Cell Types)

Cell Type	CL Term
Motor neuron	CL:0008033
Muscle fiber	CL:0000187
Neural progenitor cell	CL:0011020

UBERON Terms (Anatomy)

Structure	UBERON Term
Abducens nerve	UBERON:0001647
Oculomotor nerve	UBERON:0001643
Lateral rectus muscle	UBERON:0006312
Medial rectus muscle	UBERON:0006311
Abducens nucleus	UBERON:0002682
Pons	UBERON:0000988
Orbit	UBERON:0001693

MAXO Terms (Treatments)

Treatment Action	MAXO Term
Genetic counseling	MAXO:0000079
Surgical procedure	MAXO:0000004
Supportive care	MAXO:0000950
Physical therapy	MAXO:0000011

CHEBI Terms (Therapeutic Agents)

Agent	CHEBI Term
Botulinum toxin type A	CHEBI:85993

Key Literature Citations

PMID / ID	Description
PMID:18653847	Bhatt et al. (2008, Science 321:839–843) — Landmark paper identifying CHN1 gain-of-function mutations as the cause of familial DRS; demonstrated hyperactivated α2-chimaerin disrupts abducens axon guidance in chick embryo model
PMID:22912401	Semaphorin 3A/3C → PlexinA → α2-chimaerin signaling axis in ocular motor axon guidance and DRS; PNAS 2012
PMID:28346224	Mutant α2-chimaerin signals via bidirectional ephrin/EphA4 pathways in DRS; selective abducens vulnerability explained; JCI 2017
PMID:40212284	Etiology and clinical features of 42 Han Chinese DRS patients; CHN1 and SALL4 novel variants; MRI abducens findings; surgical outcomes; Frontiers in Genetics 2025
PMID:34033320	Duane Retraction Syndrome review; PubMed 2021
PMID:35446195	Botulinum toxin-A in adult esotropic DRS; QoL outcomes in Indian population; 2022
PMID:20230203	Diagnostic use of botulinum toxin in DRS; 2010
PMID:23477770	Botulinum toxin in esotropic DRS children ≤3 years of age; 2013
PMC:PMC7531002	CHN1 p.(Phe213Val) novel variant in large Han Chinese family with DRS
OMIM:126800	DURS1 — Duane Retraction Syndrome 1 (locus 8q13)
OMIM:604356	DURS2 — CHN1-related Duane Retraction Syndrome
OMIM:617041	DURS3 — MAFB-related DRS with or without deafness
OMIM:607323	Okihiro syndrome / DRRS — SALL4-related syndromic DRS
GeneReviews NBK1190	Duane Syndrome — GeneReviews comprehensive summary
NBK570558	Duane Retraction Syndrome — StatPearls clinical review

This report was compiled from multiple authoritative sources including GeneReviews (NBK1190), StatPearls (NBK570558), OMIM entries 126800/604356/617041/607323, primary literature (PMID:18653847, 22912401, 28346224, 40212284, 34033320, 35446195, 23477770), Orphanet ORPHA:233, Human Molecular Genetics CCDD review (26/R1/R37), and a large-cohort amblyopia review (582 patients, PMC10797543). All claims regarding molecular mechanisms are supported by peer-reviewed primary literature; epidemiological figures derive from GeneReviews and the 582-patient retrospective series.

Sources: - Duane Syndrome — GeneReviews - Duane Retraction Syndrome — StatPearls - Etiology and clinical features of Han Chinese patients with DRS — Frontiers in Genetics 2025 - Human CHN1 Mutations Hyperactivate α2-Chimaerin and Cause DRS — Science 2008 (PMID:18653847) - Mutant α2-chimaerin signals via bidirectional ephrin pathways in DRS — JCI 2017 (PMID:28346224) - Axon guidance in ocular motor system and DRS depends on Semaphorin signaling — PNAS 2012 (PMID:22912401) - Ocular CCDDs: insights into axon growth and guidance — Human Molecular Genetics 2017 - Duane Retraction Syndrome — EyeWiki AAO - Refractive features and amblyopia in DRS: 582 patients (PMC10797543) - OMIM 126800 — DURS1 - OMIM 604356 — DURS2 (CHN1) - OMIM 617041 — DURS3 (MAFB) - Duane syndrome — NORD - MONDO:0007473 — Duane retraction syndrome (OLS4) - Orphanet:233 — Duane retraction syndrome (OLS4) - Botulinum toxin-A in adult DRS — QoL outcomes (PMID:35446195) - Duane syndrome where and how is the abducens nerve — PMC 2022

Ask OpenScientist

OpenScientist Report

Inheritance

Subtypes

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Source YAML

References & Deep Research

References

Deep Research

1. Disease Information

Overview

Key Identifiers

Synonyms and Alternative Names

Evidence Basis

2. Etiology

Disease Causal Factors

Genetic Risk Factors

Environmental Risk Factors

Protective Factors

Gene–Environment Interactions

3. Phenotypes

Primary Ocular Phenotypes

Non-Ocular Phenotypes (Syndromic Forms)

4. Genetic/Molecular Information

Causal Genes

Pathogenic Variants

Molecular Yield in DRS

Modifier Genes

Epigenetic Information

Chromosomal Abnormalities

5. Environmental Information

Environmental Factors

Infectious Agents

Lifestyle Factors

6. Mechanism / Pathophysiology

Overview of Pathological Cascade

Molecular Pathways

Cellular Processes Involved

Cell Types Involved

Histopathology / Tissue-Level Findings

Subcellular / Protein Dysfunction

Biochemical Abnormalities

7. Anatomical Structures Affected

Primary Nervous System Structures

Secondary Anatomical Structures

Lateralization

8. Temporal Development

Onset

Disease Course

Progression Pattern

Critical Periods

9. Inheritance and Population

Epidemiology

Inheritance Pattern

Penetrance and Expressivity

De Novo Variants

Founder Effects / Population Genetics

Carrier Frequency

Geographic Distribution

10. Diagnostics

Clinical Diagnosis

Genetic Testing

Differential Diagnosis

Screening

11. Outcome / Prognosis

Life Expectancy

Visual Prognosis

Surgical Outcomes

Morbidity

Quality of Life

Prognostic Factors

12. Treatment

Non-Surgical Interventions

Surgical Treatment (Primary Intervention)

Experimental / Investigational Treatments

13. Prevention